- In 2021, Boston Scientific acquired Farapulse, Inc., specializing in non-invasive Atrial Fibrillation treatment devices. This acquisition expands Boston Scientific's portfolio in minimally invasive electrophysiological treatments, potentially including pelvic floor electrical stimulation therapy. With Farapulse's expertise, Boston Scientific aims to strengthen its position and offerings in the pelvic floor electric stimulator market
- In 2020, Laborie's acquisition of Clinical Innovations for USD 525 million, a major player in Labor & Delivery and Neonatal Intensive Care Unit devices, is poised to fortify their industry presence. This strategic move anticipates reinforcing their position in the pelvic floor electric stimulator market, enhancing competitiveness and market share
- In 2020, Atlantic Therapeutics partnered with the HARTMANN Group, a prominent medical goods supplier, in a strategic distribution deal. HARTMANN will distribute Atlantic Therapeutics' Innovo therapy device for urinary incontinence to German women. This collaboration strengthens Atlantic Therapeutics' presence in the pelvic floor electric stimulator market, expanding their reach and accessibility
- In 2020, Medtronic announced the InterStim Mini system, featuring a compact implantable device for sacral Neuromodulation therapy targeting bladder and bowel control issues. This innovation incorporates a small, rechargeable battery, offering patients a less invasive treatment option. It enhances options within the pelvic floor electric stimulator market, catering to patient preferences and needs
